Nutex Health (NASDAQ:NUTX) Coverage Initiated at Maxim Group
by Doug Wharley · The Cerbat GemMaxim Group initiated coverage on shares of Nutex Health (NASDAQ:NUTX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The brokerage issued a buy rating and a $45.00 price target on the stock.
Separately, Benchmark increased their price target on Nutex Health from $30.00 to $45.00 and gave the company a buy rating in a report on Wednesday, August 21st.
View Our Latest Analysis on Nutex Health
Nutex Health Stock Performance
Shares of NUTX opened at $24.50 on Wednesday. The company has a market capitalization of $121.81 million, a price-to-earnings ratio of -2.31 and a beta of 0.08. The company has a debt-to-equity ratio of 3.04, a quick ratio of 1.55 and a current ratio of 1.59. Nutex Health has a 1 year low of $4.16 and a 1 year high of $45.00. The company’s 50 day simple moving average is $15.55 and its 200 day simple moving average is $10.97.
Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.22. The firm had revenue of $76.08 million for the quarter. Nutex Health had a negative return on equity of 43.79% and a negative net margin of 13.73%.
Insider Activity at Nutex Health
In related news, CFO Jon Christian Bates purchased 1,350 shares of Nutex Health stock in a transaction dated Thursday, August 22nd. The stock was acquired at an average cost of $21.46 per share, with a total value of $28,971.00. Following the completion of the transaction, the chief financial officer now directly owns 2,277 shares of the company’s stock, valued at $48,864.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 38.52% of the company’s stock.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Nutex Health stock. Beaird Harris Wealth Management LLC grew its holdings in Nutex Health Inc. (NASDAQ:NUTX – Free Report) by 210.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 930,282 shares of the company’s stock after purchasing an additional 630,168 shares during the quarter. Beaird Harris Wealth Management LLC owned about 0.14% of Nutex Health worth $167,000 as of its most recent filing with the SEC. Institutional investors own 5.32% of the company’s stock.
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.